Long-term, low-dose immunosuppression for myasthenia does not affect collateral, asymptomatic sclerosing cholangitis.
Josef
J
Finsterer
Sonja
S
Höflich
D000368:Aged; D058070:Asymptomatic Diseases / Q000628:therapy; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects; D015209:Cholangitis, Sclerosing / Q000276:immunology*; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D009157:Myasthenia Gravis / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D001379:Azathioprine